Viewing Study NCT06574412


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT06574412
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-28
First Post: 2024-08-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.
Sponsor: The First Hospital of Jilin University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module